Weak US data hampers FTSE recovery

Market heavyweights AstraZeneca and embattled BP made steady gains today, but weak US jobs data limited the recovery on the wider FTSE 100 Index.

Market heavyweights AstraZeneca and embattled BP made steady gains today, but weak US jobs data limited the recovery on the wider FTSE 100 Index.

The FTSE 100 made subdued progress as survey data showed far lower than expected jobs growth among US private employers in June.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited